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Abstract
Cleft palate (CP) is one of the most commonly occurring craniofacial birth defects in humans. In order to study cleft palate in
a naturally occurring model system, we utilized the Nova Scotia Duck Tolling Retriever (NSDTR) dog breed. Micro-computed
tomography analysis of CP NSDTR craniofacial structures revealed that these dogs exhibit defects similar to those observed
in a recognizable subgroup of humans with CP: Pierre Robin Sequence (PRS). We refer to this phenotype in NSDTRs as CP1.
Individuals with PRS have a triad of birth defects: shortened mandible, posteriorly placed tongue, and cleft palate. A
genome-wide association study in 14 CP NSDTRs and 72 unaffected NSDTRs identified a significantly associated region on
canine chromosome 14 (24.2 Mb–29.3 Mb; praw = 4.64610
215). Sequencing of two regional candidate homeobox genes in
NSDTRs, distal-less homeobox 5 (DLX5) and distal-less homeobox 6 (DLX6), identified a 2.1 kb LINE-1 insertion within DLX6
in CP1 NSDTRs. The LINE-1 insertion is predicted to insert a premature stop codon within the homeodomain of DLX6. This
prompted the sequencing of DLX5 and DLX6 in a human cohort with CP, where a missense mutation within the highly
conserved DLX5 homeobox of a patient with PRS was identified. This suggests the involvement of DLX5 in the development
of PRS. These results demonstrate the power of the canine animal model as a genetically tractable approach to
understanding naturally occurring craniofacial birth defects in humans.
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Introduction
Cleft palate (CP) is one of the most commonly occurring
craniofacial birth defects, affecting approximately 1 in 1500 live
human births in the United States [1]. Children born with CP
may develop hearing loss, difficulties with speech and eating, and
may be at an increased risk for psychiatric disorders and
neurological deficits [2–4]. CP occurs when there is a failure in
the formation of the secondary palate, which makes up all of the
soft palate and majority of the hard palate. Secondary palate
development is conserved across mammalian species and
proceeds through highly regulated sequential steps: palatal shelf
growth, elevation, fusion, and cell differentiation (reviewed in
[5]). Disruptions in any of these pathways may cause a cleft palate
and lead to the phenotypic spectrum of CP cases that is observed.
CP may occur alone (nonsyndromic) or with other abnormalities
(syndromic).
Pierre Robin sequence (PRS, OMIM 261800) is a heterogeneous
and phenotypically variable subgroup of CP that affects 1 in 8500
live human births [6]. PRS is characterized by a cleft palate,
shortened mandible (micrognathia), and posteriorly placed tongue
(glossoptosis). PRS is thought to be the result of a sequence of events
caused by the primary defect, micrognathia [7]. The etiology of
PRS is still largely unknown and highly variable. PRS may occur
alone or as part of a syndrome, such as Stickler syndrome,
Velocardiofacial syndrome, and Treacher Collins syndrome [8,9].
A high incidence within families and among twins suggests a genetic
etiology. Familial aggregation with an autosomal dominant mode of
inheritance has been observed with translocations of 17q24 and a
reduction of SOX9 and KCNJ2 expression [10,11]. PRS also
occurs at a high incidence among families with cleft lip and palate
[12,13]. However, monozygotic twins discordant for PRS are also
observed, suggesting that PRS may be a result of the twinning
process or of mandibular constraint in utero [13,14].
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In an effort to understand the genetic basis of craniofacial birth
defects such as PRS, we used a relatively unconventional model
organism, the domestic dog. Dogs have naturally occurring birth
defects, with inherited orofacial clefts that resemble those observed
in humans [15–17]. Domestication and subsequent pedigreed
breed creation from a small number of founders has led to a
unique genetic background, resulting in a small number of genetic
variants being responsible for the broad phenotypic diversity
observed [18]. Compared to humans, dogs are amendable to
association-based mapping studies with a small number of samples
due to their relatively long linkage disequilibrium blocks within
breeds [19]. Here, we demonstrate how a naturally occurring
model of PRS in the Nova Scotia Duck Tolling Retriever
(NSDTR) breed, characterized by CP and relative micrognathia,
led to the identification of both the first mutation responsible for
cleft palate in dogs and candidate genes for PRS in people.
Results
Genome-Wide Association
DNA samples were collected from 14 NSDTRs that had clefts
of the hard and soft palate. To identify loci associated with the CP
phenotype in the NSDTR, a genome-wide association was
performed in 14 CP NSDTR cases and 72 controls across
,173,000 SNPs. After quality control, 109,506 SNPs remained.
Chi-square analysis of the remaining SNPs identified an associated
region on canine chromosome 14 (cfa14; Figures 1A and 1B). A
homozygous 5.1 Mb haplotype was identified (24.2 Mb to
29.3 Mb) in 12 of the 14 CP NSDTR cases (Figure 1C). This
homozygous haplotype is absent in all 72 controls. Parents (n = 5)
and littermates (n = 6) of the 12 CP NSDTRs were heterozygous
for the associated haplotype, suggesting a recessive mode of
inheritance.
Quantile-quantile (Q-Q) plots and a genomic inflation factor of
1.05 indicate that there is no underlying population stratification
(Figure 1D). To confirm that only the association is responsible for
the deviation from the line of the null hypothesis, SNPs on cfa14
were removed and the Q-Q plot regenerated. There is little
evidence of population stratification with a recalculated genomic
inflation factor of 1.02.
Using microsatellite markers from the cfa14 interval, linkage
analysis was performed on a subset of CP NSDTRs with the
associated haplotype and available family members (n = 8). LOD
scores were calculated under a fully penetrant recessive mode of
inheritance (Table S1). A significant LOD score of 3.18 was
obtained with a recombination fraction (H) of zero at
cfa14.25006375, further confirming the association.
CP and Mandibular Abnormalities in NSDTRs
All 14 CP NSDTRs had clefts of the hard and soft palate
(Figures 2A and 2B), but the 12 CP NSDTRs with the associated
haplotype exhibited a specific phenotype, which we designate CP1
(Cleft Palate 1). Micro-computed tomographic (micro-CT) imag-
ing was performed to investigate additional craniofacial abnor-
malities on available skulls from 4 neonatal CP1 NSDTRs and 3
neonatal normal NSDTRs with the homozygous wildtype
haplotype. One of the mandibles from the 4 CP1 NSDTRs was
unavailable for imaging. Uneven alignment of the upper and lower
jaw was noted in the 3 CP1 NSDTRs when compared to the 3
normal NSDTRs indicating relative mandibular brachygnathia
(Figures 2C and 2D). 3D measurements of the mandible length
indicated that the CP1 NSDTRs had relatively shorter mandibles
by an average of 5.46 mm when compared to the normal
NSDTRs (Table S2). In the 4 cases, clefts were characterized by
abnormal or missing palatine fissures, missing or small palatine
processes of the maxilla, and small, missing, or abnormally shaped
palatine bones (Figures 2E–2G). The nasal septum was absent or
poorly developed. In the three CP1 NSDTR with mandibles,
variation from the normal angulation of the condylar process was
observed (Figure 2H). In two of these cases, an abnormal angle of
the mandibular head of the condylar process was observed. One
case had an additional general asymmetry of the entire cranio-
facial complex. Based on the phenotypic findings, we hypothesize
that the 12 CP1 NSDTRs are animal models for cleft palate and
micrognathia disorders.
Although unavailable for micro-CT imaging, the 2 CP cases
without the associated haplotype exhibited a normal jaw
relationship with no relative mandibular brachygnathism. Since
these dogs are phenotypically different, they were excluded from
the rest of the analysis.
Sanger Sequencing of DLX5 and DLX6
Located within the interval defined by the genome-wide
association study are 21 genes (Table S3). DLX5 and DLX6
(cfa14: 25014704-25033706) were selected for sequencing due to
their roles as transcription factors in craniofacial development and
the similar phenotypes observed in mutant mice [20–22]. The
coding regions and intronic regions with high conservation across
species of DLX5 and DLX6 were sequenced in one CP1 case and
one unaffected control NSDTR. One intronic nucleotide insertion
(25032667-25032667insG) was identified within DLX5 in both the
CP1 case and unaffected control NSDTRs when compared to the
CanFam 2.0 Boxer reference sequence [19]. Upon further
investigation in additional NSDTRs, it was observed that this
insertion does not segregate with the phenotype and is likely breed
specific. A 2056 bp insertion was identified within a highly
conserved region of DLX6 intron 2 at cfa14.25016716 in the CP1
case when compared to the unaffected control and reference
sequence. The insertion is 82 bp into intron 2 and is flanked by a
13 bp target site duplication. A BLAST search identified 99%
similarity with a LINE-1 element (GenBank AC187025.7) [23].
Transcription of the LINE-1 Element
Transcript analysis was performed in cDNA from cerebral
cortex for both DLX5 and DLX6. DLX5 and DLX6 transcripts
were Sanger sequenced in one neonatal CP1 NSDTR with the
LINE-1 insertion and compared to one neonatal unaffected
control NSDTR. No polymorphisms were identified within
Author Summary
Cleft palate is one of the most commonly occurring birth
defects in children, and yet its cause is not completely
understood. In order to better understand cleft palate we
have turned to man’s best friend, the domestic dog.
Common breeding practices have made the dog a unique
animal model to help understand the genetic basis of
naturally occurring birth defects. A genome-wide associ-
ation study of Nova Scotia Duck Tolling Retrievers with
naturally occurring cleft palate led to the investigation of
two homeobox genes, DLX5 and DLX6. Dogs with this
mutation also have a shortened lower jaw, which
resembles those who have Pierre Robin Sequence (PRS).
Investigation into people with PRS identifies a mutation
within a highly conserved and functional region of DLX5
that may contribute to the development of PRS. This
exemplifies how the dog will help us better understand
common birth defects.
A Canine Model of Pierre Robin Sequence
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DLX5. cDNA from the CP1 NSDTR showed both the wildtype
DLX6 transcript and a larger transcript, which contained 1281
base pairs of the intronic LINE-1 insertion (Figure 3B).
In order to quantify the amount of both wildtype DLX6
transcript and the larger mutant DLX6 transcript, real-time PCR
of DLX6 from cerebral cortex cDNA was performed in 3 neonatal
CP1 NSDTRs and 3 neonatal unaffected control NSDTRs. REST
analysis indicated that in CP1 NSDTRs, when compared to
control NSDTRs, the DLX6 wildtype transcript was downregu-
lated by a mean factor of 0.252 (p = 0.069), while the DLX6
mutant transcript was significantly upregulated by a mean factor
of 60.033 (p= 0.012; Figures 3C and 3D) [24]. Real-time PCR
was also performed on DLX5 in the same samples. There was no
significant change in DLX5 expression levels between CP1 cases
and unaffected controls in the tissues examined.
Sequence analysis and translation of the approximately 1.2
kilobase LINE-1 insertion predicts an in frame stop codon after the
insertion of a new exon (Figure 4). A premature stop codon is
predicted to truncate 17 amino acids from the 60 amino acid
functional DNA binding homeodomain.
Segregation Analysis and Allele Frequency
In order to investigate segregation of the DLX6 LINE-1
insertion, PCR genotyping was performed on available DNA from
parents, littermates, and the 12 CP1 NSDTRs (Figure 5). All 12
CP1 NSDTRs with the associated haplotype were homozygous for
the LINE-1 insertion or mutant allele. Within families of the 12
CP1 NSDTRs, nine parents and 17 littermates were available for
genotyping. Nine parents and 14 littermates were heterozygous for
the mutant allele, while the 3 remaining littermates were
homozygous for the wildtype allele. This indicates that the
DLX6 LINE-1 insertion segregates both with the phenotype and
with an autosomal recessive mode of inheritance.
Additional dogs were PCR genotyped to determine the allele
frequency of the DLX6 LINE-1 insertion (Table 1). Within the
NSDTR breed, 96 dogs were genotyped and 80 NSDTRs did not
carry the insertion, while the remaining 16 NSDTRs were
heterozygous for the insertion. To determine if the insertion was
shared among other breeds, 35 affected dogs from 20 other breeds
and 284 unaffected dogs from 69 breeds were genotyped. No
carriers were identified. This is consistent with a fully penetrant
Figure 1. Genome-wide association study results of NSDTRs with CP. A. Manhattan plot of 2log10 of raw p-values by chromosome. The
pgenome value is the p-value after 100000 permutations. The lowest pgenome is found across 8 SNPs on cfa14: 25822897, 25832747, 25847915,
25854827, 25868609, 25995782, 26023199, and 26082330. B. Plot of the raw p-values by Mb on cfa14 depicting the associated region. C. Observed
haplotypes in 12 CP NSDTRs. Horizontal bars represent haplotypes from the 12 CP NSDTRs with associated haplotype, with runs of homozygosity in
grey. The critical interval is defined by the shared homozygous haplotype denoted by the black bars (cfa14. 24189817-29319290). The 2 CP NSDTRs
without the associated haplotype are not included in this figure. D. Quantile-Quantile plot of genome-wide association results. Black dots represent
the observed versus expected p-values of all SNPs (l=1.05). Grey dots represent the observed versus expected p-values after removal of all SNPs on
cfa14. (l=1.02). The solid grey line represents the null hypothesis: observed p-values equal expected p-values.
doi:10.1371/journal.pgen.1004257.g001
A Canine Model of Pierre Robin Sequence
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autosomal recessive causative mutation that is private to the
NSDTR breed.
Screening of Human Cleft Palate Cases
To determine if variation in DLX5 or DLX6 contributed to
cleft palate in humans, a cohort of patients with a variety of
manifestations of cleft palate were sequenced. Sequencing of 59
patients with nonsyndromic CP (NSCP) and 92 patients with
nonsyndromic clefting of the lip and palate (NSCLP) identified 7
novel intronic or 39UTR variants (Table 2). The intronic variant
at chr9: 96635849 was present in 1.25% of chromosomes and was
absent from 1000 Genomes (p = 0.03) [25]. However, none of the
variants was significantly associated when correcting for multiple
comparisons. To test for overtransmission of a common allele to
affected offspring, a set of 362 case-parent trios from the US were
genotyped across a subset of SNPs (rs2272280, rs3801290, and
Figure 2. Phenotype of neonatal CP1 NSDTRs. A. Neonatal CP1 NSDTR with an extensive cleft of the hard and soft palate. B. Neonatal NSDTR
with a normal palate (WT). C. Lateral view of CP1 head exhibiting relative mandibular brachygnathia. D. Lateral view of WT head with a normal jaw
relationship. E. Coronal CT image depicting the failure of the palatine processes and nasal septum to fuse in CP1 NSDTRs. F. Coronal CT image
depicting midline fusion of palatal process and nasal septum in WT. P – Palatine process, NS – Nasal septum G. 3D reconstruction of microCT imaging
of CP1 and WT skulls with mandibles removed. CP1 skull shows abnormally shaped palatine process and palatine bones. Bones colored blue are the
palatine processes and palatine bones. WT skull shows anatomical location of normal palatine sutures and shape of palatine processes and palatine
bones. H. 3D reconstruction of mandibles depicting abnormal angulation of the condylar process (*) in CP1 mandibles compared to WT mandibles.
doi:10.1371/journal.pgen.1004257.g002
A Canine Model of Pierre Robin Sequence
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rs3213654) and tested with TDT analysis. These SNPs were not
significantly associated with NSCLP or NSCP (p.0.4, data not
shown).
The screening of 31 patients with syndromic CP identified 4
novel rare variants, two of which were protein coding (Table 2).
These include a synonymous variant at p.Phe282 and a novel
missense variant in a patient with PRS (DLX5: p.Ile192Met;
NM_005221.5:c.576C.G). The missense variant was predicted to
be damaging by SIFT, but was inherited from the affected
individual’s unaffected mother. However, this variant affects a
Figure 3. PCR amplification and expression analysis of LINE insertion in CP1 and WT NSDTRs. A. Gel image of long range PCR
amplification of the DLX6 intronic LINE-1 insertion from genomic DNA of an unaffected NSDTR (WT; 2500 bp band), CP1 NSDTR (CP1; 4600 bp band),
and negative water control (Neg). CP1 has a 2.1 kb LINE insertion. B. Gel image of RT-PCR amplification of DLX6 from WT and CP1 cDNA. CP1
expresses both a wildtype (1390 bp) and mutant (2600 bp) transcript. The mutant transcript has a 1.2 kb insertion. GAPDH was used to control for
cDNA concentrations. C. Relative DLX6 gene expression ratios by transcript of cerebral cortex cDNA from 3 neonatal CP1 NSDTRs compared to 3
neonatal WT NSDTRs. Boxes represent the interquartile range, and the dotted lines within represent median gene expression. Whiskers of the boxplot
represent minimum and maximum observations. Relative expression levels were normalized to the housekeeping gene, B2M. Statistical significance is
reported as p,0.05(*). D. Summary of relative expression of wildtype and mutant DLX6 transcripts of CP1 NSDTRs compared to WT NSDTRs. Fold
change and p-values were calculated using REST2009 [24].
doi:10.1371/journal.pgen.1004257.g003
Figure 4. Schematic illustration of genomic and cDNA DLX6 gene structure in unaffected (WT) and CP1 NSDTRs (CP1). Nucleotides
boxed and in bold are the 13 base pair target site duplication identified as part of the DLX6 LINE-1 insertion. Conservation represents the UCSC
genome browser comparative genomics conservation track of human, dog, mouse, and rat sequence conservation. The region of conservation
represented in red is the region disrupted by the LINE-1 insertion. Image is not drawn to scale.
doi:10.1371/journal.pgen.1004257.g004
A Canine Model of Pierre Robin Sequence
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highly conserved residue of the DNA-binding domain of DLX5
that is conserved across vertebrates and was absent from both the
1000 Genomes and NHLBI ESP databases [25,26]. An additional
15 patients with Pierre Robin sequence were sequenced, but no
additional mutations were identified.
Discussion
A naturally occurring animal model for PRS was discovered in
twelve cases of CP1 NSDTRs, which exhibit relative mandibular
brachygnathia and cleft palate. A genome-wide association study
within NSDTRs with CP identified a shared 5.1 Mb homozygous
haplotype among 12 CP1 cases with relative mandibular
brachygnathia. From the associated interval, DLX5 and DLX6
were selected as regional candidate genes based on their roles in
development. Sequencing of these regional candidate genes in
NSDTRs identified an intronic LINE-1 insertion within DLX6
that segregates with the phenotype in the breed. This discovery
prompted the sequencing of the same genes in a human cohort of
CP cases, which identified a damaging missense mutation within
the homeobox of DLX5 in a patient with PRS was identified.
The regional candidate genes, DLX5 and DLX6, make up a pair of
convergently transcribed homeobox containing transcription factors
[27]. They are involved in patterning of craniofacial structures, inner
ear, limb, and brain development with roles in chondrocyte and
osteoblast differentiation [21,28,29]. The functions of Dlx5 and Dlx6
were studied by targeted inactivation of murine homologs. Develop-
mental expression of both genes was observed in the first pharyngeal
arch, brain, and skeleton [27]. Single gene mutants (Dlx52/2 and
Dlx62/2) were perinatal lethal and resulted in brain, bone, and inner
ear defects, with craniofacial abnormalities including a cleft palate,
hypoplastic condylar process, and shortened mandible [20–22].
Double mutants (Dlx52/2;DLX62/2) exhibited more severe cranio-
facial, inner ear, and bone defects, and were a phenocopy of split
hand/foot malformation [28]. They also exhibited homeotic transfor-
mation of the mandible into a maxilla indicating that these genes were
responsible for normal patterning of the mandible [21,28,29].
Phenotypic similarity between CP1 NSDTRs, the PRS patient,
and mutant mice are observed with the changes in the condylar
process, cleft palate, and relatively shortened mandibles. There
may be associated condylar hypoplasia in PRS, but this was not
investigated in the PRS patient [30,31]. Shortened mandibles have
Figure 5. Pedigree of 7 CP1 NSDTR families depicting segregation of the mutant allele with the LINE-1 element insertion. Filled
symbols represent NSDTRs with the CP1 phenotype. Diagonal lines indicate that the NSDTR is deceased. ‘‘+’’ represents wildtype allele. ‘‘m’’
represents the mutant allele. [ ] genotypes were inferred if DNA was not available.
doi:10.1371/journal.pgen.1004257.g005
Table 1. Summary of allele frequencies of genotyping results.
Sample N Allele Frequencya
NSDTRs 96 17%
Non NSDTRs with cleft 35 0%
Non NSDTRs 284 0%
aAllele frequencies indicate the number of individuals with at least one copy of the mutant allele.
doi:10.1371/journal.pgen.1004257.t001
A Canine Model of Pierre Robin Sequence
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been observed to cause cleft palate in mouse studies [7,32–34].
Palatal development is a highly regulated sequence of events
involving the repositioning of the palatal shelves from a lateral to
horizontal orientation over the tongue. During this process, the
tongue repositions by elongation of the mandible, allowing for
reorientation of the palatal shelves (reviewed in [5]). If the
mandible does not elongate, the tongue cannot reposition, which
in turn obstructs palatal shelf elevation and leads to a cleft palate
[7]. This supports the role of DLX5 and DLX6 in the phenotype
observed in the PRS patient and CP1 NSDTRs. This also suggests
that the CP1 NSDTRs are naturally occurring animal models for
PRS because, although other disorders may be associated with
cleft palate and micrognathia, these dogs lack additional abnor-
malities [35].
DLX5 and DLX6 contain homeoboxes that regulate transcrip-
tion by binding to specific DNA sequences. Homeoboxes are
highly conserved nucleotide sequences of 180 base pairs. Point
mutations located within the homeobox give rise to disease at a
higher frequency than mutations located within the rest of the
gene and often show a dominant effect due to haploinsufficiency
[36]. DLX5 is sensitive to haploinsufficiency because, although
Dlx5+/2 mice appear normal, closer investigation indicates that
they have a decreased bone mineral density [20,37]. Mutations
within the homeobox may also affect proper structural folding of
the protein and DNA binding specificity leading to a mutant
phenotype [38]. This is observed in a homozygous missense
mutation in the homeobox of DLX5 in two affected family
members in a consanguineous pedigree with split-hand/foot
malformation (SHFM) [39]. The affected individuals were noted
to have clefts of the hands, but no cleft palate or craniofacial
abnormalities with the exception of a mildly pronounced forehead.
The heterozygous missense mutation identified in the PRS patient
(NM_005221.5:c.576C.G) is located within the homeobox
sequence of DLX5, which supports it contribution to the observed
phenotype.
The DLX5 heterozygous missense mutation within the PRS
patient does not segregate with a Mendelian mode of inheritance, but
this is not expected since PRS is a complex trait. PRS was not
apparent in the mother, but she may have exhibited subtle
craniofacial abnormalities that went unnoticed. This likely complex
inheritance suggests a role for additional, not yet identified loci or
environmental factors. Support for this is observed when mice with
heterozygous expression of a Dlx5 null allele and targeted inactivation
of a transcription factor responsible for clefting in people, Msx1,
exhibit cleft palate (Dlx52/+; Msx12/2) [40]. However, when
expression of both genes is disrupted (Dlx52/2; Msx12/2), mice
have no cleft palate.
Nine noncoding sequence variants were identified within DLX5
and DLX6 of human patients with orofacial clefts. Functional
analysis of the nine variants may provide further insight into the
possible contribution of these genes to a cleft palate phenotype.
Noncoding regions have important regulatory functions as they
have been observed to disrupt gene expression. Reduced DLX5
and DLX6 expression was observed in an autistic patient with a
SNP in the DLX5 and DLX6 intergenic region [41]. Hearing loss
and craniofacial defects including cleft palate and micrognathia
have been observed in the deletion of a DLX5 and DLX6
enhancer region [42]. The LINE-1 insertion within DLX6 of the
CP1 NSDTRs is also located within a noncoding region that is
highly conserved. According to the UCSC genome browser, the
HMR conserved transcription factor binding site regulation track
indicates that the LINE-1 insertion identified within DLX6 CP1
NSDTRs disrupts a binding domain for SUZ12. SUZ12 is a long
noncoding RNA that encodes a core of the polycomb repressive
complex2 that has regulatory functions in the developing embryo
[43]. The exact interaction of SUZ12 and DLX6 is not yet known,
indicating that the LINE insertion may do more than disrupt
transcription.
LINE elements are transposable elements that comprise 21% of
the human genome, 16% of the dog genome, and often insert into
intronic regions [44,45]. Intronic LINE element insertions are
observed to cause disease in Duchenne-like muscular dystrophy
and chronic granulomatous disease through the introduction of a
new exon [46–48]. cDNA sequence from CP1 NSDTRs
homozygous for the LINE-1 insertion indicate that 1 kb of the
LINE element is spliced into the DLX6 transcript. Premature
protein truncation of DLX6 is predicted due to an in frame stop
codon after the formation of a new exon. Both the Dlx6 mutant
mice (Dlx62/2) and CP1 NSDTRs phenotypes are the result of
truncating the same 39 sequence of the homeodomain [22].
The LINE insertion disrupts transcription of DLX6 within CP1
NSDTRs and leads to downregulation of wildtype DLX6
transcript when compared to unaffected NSDTRs. As a result,,
only 25% of the normal expression levels are produced. The
reduced expression of wildtype DLX6 transcript is not enough to
prevent CP and the mandibular abnormalities. DLX5 and DLX6
expression levels have been observed to vary based on the
timepoint and tissue examined with complex transcriptional
regulation from tissue specific enhancers and noncoding RNAs
[20,21,27,28,42,49–51]. It is possible that the LINE insertion
works to disrupt appropriate timing of tissue specific expression
since it is inserted into a highly conserved region within intron 2.
Although not statistically significant, expression analysis from
additional biological replicates from the correct tissue during the
correct embryonic timepoint would likely yield significant values in
the CP1 NSDTRs.
This discovery provides a genetic tool for the NSDTR breeder
who wishes to avoid producing cleft palate affected puppies. The
LINE insertion identified within the CP1 NSDTRs is unique to a
subset of cases with CP within the breed and cannot be used as a
tool to prevent against all genetic causes of CP. CP disease
heterogeneity is observed in the NSDTR breed as 2 of the 14 CP
cases did not possess relatively shortened mandibles and the
associated LINE-1 insertion. This is unexpected in a purebred
dog breed with few founders where the inbreeding coefficient is
0.26 [52]. This indicates that even in relatively genetically
homogenous samples, heterogeneity and a complex etiology that
mimics human cleft cases such as PRS is observed. This
highlights the promise of the dog as an animal model for birth
defects to identify multiple genes and/or pathways involved in
craniofacial development.
In summary, identifying a mutation in an animal model with
naturally occurring birth defects has enabled the identification of
new candidate genes for PRS in people. This supports the
continued use of the naturally occurring birth defects found within
dogs and their unique genetic background to further our
understanding of commonly occurring birth defects in people.
Materials and Methods
Ethics Statement
The use of samples involving human participants was approved by
the institutional review board at the University of Iowa (approval #s
199804080 and 199804081). Informed consent was obtained and all
clinical investigation was conducted according to the principles
expressed in the Declaration of Helsinki. The collection of canine sam-
ples used in this study was approved by the University of California,
Davis Animal Care and Use Committee (protocol #16892).
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Canine Samples and DNA Extraction
Blood and tissue samples from NSDTRs with cleft palate
(n = 14), healthy littermates (n = 24), parents (n = 11), unaffected
NSDTRs (n= 153), and dogs with cleft palate across 20 breeds
(n = 35) were collected from privately owned animals. When
available, tissue was collected at post mortem examination and
flash frozen. The evaluations of orofacial clefts were performed by
visual inspection of affected dogs. Blood samples from unaffected
dogs (n = 284) across 69 other breeds were collected from the
William R. Pritchard Veterinary Medical Teaching Hospital.
Genomic DNA was extracted from EDTA whole blood and tissue
samples using Gentra Puregene DNA purification extraction kit
(Qiagen, Valencia, CA).
Genome-Wide Association Study
Genome-wide SNP genotyping was performed with 14 cases
and 72 controls using the Illumina CanineHD BeadChip
(Illumina, San Diego, CA) with 173,662 markers. Samples had a
genotyping call rate of $90%. 63,195 SNPs were excluded due to
a minor allele frequency of #0.05 and 2,994 SNPs were excluded
for a missing call rate of #10%. Chi-square analysis was
performed using Plink [53]. 100,000 permutations were performed
to correct for multiple tests. To determine if population
stratification was present, quantile- quantile plots were generated
in R using Plink output data [54]. The genomic inflation factor
was also calculated using Plink.
CT Imaging
High-resolution micro-computed tomography (micro-CT) was
used to evaluate craniofacial structures in 4 CP1 NSDTRs that
were homozygous for the LINE-1 insertion, and in 3 normal
NSDTRs homozygous for the wildtype allele. Samples were
imaged at the Center for Molecular and Genomic Imaging (UC
Davis). The skulls were kept in zip-lock bags and allowed to warm
to the CT scanner temperature (29uC) inside of a custom plastic
holder. CT images were obtained on the Centers MicroXCT-200
specimen CT scanner (Carl Zeiss X-ray Microscopy). The CT
scanner has a variable x-ray source capable of a voltage range of
20–90 kV with 1–8W of power. Samples were mounted on the
scanners sample stage, which has submicron level of position
adjustments. Scan parameters were adjusted based on the
manufacturer’s recommended guidelines: source and detector
distances were 108 mm and 35 mm, respectively; the manufac-
turers LE4 custom filter was used for beam filtration; the voltage
and power were set to 70 kV and 8W, respectively; and 1600
projections were acquired over 360-degrees with an exposure time
of 1.5 s. Images were reconstructed on an isotropic voxel grid with
51.1507 microns per edge. Digital TIFF images were imported
into Amira 5.4.5 (Visualization Sciences Group, FEI) For all
specimens, tridimensional reconstructive (3D) images were gener-
ated to assess the spatial relationship of the bones. 3D length
measurements were performed using the 3D length tool. Visual
inspection of the micro-CT images was performed to identify any
abnormalities.
PCR Amplification of Microsatellites and Linkage Analysis
Four regional microsatellites were mined from the UCSC
genome browser (CanFam 2.0) ‘‘Variation and Repeats’’ database
within cfa14: 24.2 Mb–29.3 Mb. Fluorescently labeled microsat-
ellite primers were designed (Table S4) using Primer3 [55].
Microsatellites were PCR amplified using the following protocol:
94uC for 12 minutes, 7 cycles of 93uC for 20 seconds, 65uC for
30 seconds, 72uC for 2 minutes, 5 cycles of 93uC for 20 seconds,
58uC for 30 seconds, 72uC for 2 minutes, and 25 cycles of 93uC
for 20 seconds, 55uC for 30 seconds, 72uC for 2 minutes, followed
by a final annealing of 72uC for 2 minutes. Genotyping was
performed on an ABI 3100 Genetic Analyzer (Applied Biosystems,
CA) in 8 CP1 NSDTRs and 32 control NSDTRs. All genotypes
were analyzed using STRand software [56]. LOD score analysis of
microsatellite data was performed using Mendel software’s
LOCATION_SCORES option in 59 individuals from three
pedigrees [57]. The disease trait was coded as autosomal recessive
and assumed to be fully penetrant.
Sequencing of Candidate Genes
Primers to amplify the exons, intron/exon boundaries, and
regions of high conservation within the intragenic and intergenic
regions of DLX5 and DLX6 were designed in Primer3 (Table S3)
[55]. PCR products were amplified in one CP1 NSDTR and one
unaffected NSDTR. Areas with high GC content were amplified
using Invitrogen AccuPrime GC-Rich DNA Polymerase protocols
(Life Technologies, Grand Island, NY). PCR products were
cleaned using ExoSAP-IT and sequenced using the Big Dye
terminator mix on an ABI 3100 Genetic Analyzer (Applied
Biosystems, CA). Sequences were analyzed using Chromas
(Technelysium, Tewantin, QLD, Australia) and Vector NTI
(Informax, Frederick, MD). Sequences were aligned to each other
and the Boxer reference sequence (CanFam 2.0) to identify any
polymorphisms [19]. The DLX6 LINE-1 insertion was amplified
using LongAmp Taq PCR Kit (New England BioLabs Ipswich,
MA) and cloned using the Invitrogen TOPO TA Cloning kit
(pCR2.1-TOPO vector) with One Shot TOP10 Chemically
Competent E. coli. Products were isolated with the Qiaprep Spin
Miniprep kit (Qiagen, Valencia, CA) and sequenced using an ABI
3100 Genetic Analyzer (Applied Biosystems, CA). LINE element
sequence was identified using BLAST 2.2.28 [23].
RNA Extraction/cDNA Sequencing
Expression of DLX5 and DLX6 was evaluated in NSDTR
lymphocytes, unaffected adult beagle tissue from cerebellum,
cerebral cortex, heart, kidney, liver, skeletal muscle, skin, spinal
cord, spleen, testis, and thymus. Total RNA was isolated from
tissue samples using Qiagen QIAamp Blood Mini Kit (Valencia,
CA) tissue protocols. Adult beagle total RNA was obtained from
Zyagen (San Diego, CA). RNA was synthesized into cDNA using
Invitrogen Superscript III First Strand Synthesis System to RT
PCR kit (Life Technologies, Grand Island, NY). GAPDH was
amplified (forward primer 59AAGATTGTCAGCAATGCCTCC
39 and reverse primer 59 CCAGGAAATGAGCTTGACAAA 39)
in these tissues to ensure that equivalent amounts of cDNA were
added. Invitrogen 59 prime RACE system for Rapid Amplification
of cDNA ends kit (Life Technologies, Grand Island, NY) was used
to sequence the 59 prime end of DLX6 from embryo cDNA.
RACE primers were designed using Primer3 (Table S3) [55].
RACE PCR products were cloned using the Invitrogen TOPO
TA Cloning kit (pCR2.1-TOPO vector) with One Shot TOP10
Chemically Competent E. coli. Products were isolated with the
Qiaprep Spin Miniprep kit (Qiagen, Valencia, CA) and sequenced
using an ABI 3100 Genetic Analyzer (Applied Biosystems, CA).
Genotyping
Genotyping primers were designed using Primer3 [55]. PCR
genotyping was performed using a shared FAM labeled forward
primer (59 ACCATCGCTTTCAGCAAACT 39). Unlabeled
reverse primers specific for the LINE-1 insertion (59 GCAACTAA-
TATTCGATAAAGCAGAA 39) and wildtype (59 CTAG-
GCCCAGAATTCCTCCT 39) were designed. The PCR program
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was as follows: 94uC for 12 minutes, 35 cycles of 94uC for
30 seconds, 58uC for 30 seconds, and 72uC for 45 seconds,
followed by 72uC for 20 minutes. The wildtype product produced
a 171 base pair product and the mutant product produced a 184
base pair product. GeneScan 500 ROX size standards were used
and the reaction was analyzed on an ABI 3100 Genetic Analyzer
(Applied Biosystems, CA). 96 unrelated unaffected NSDTRs and
284 unaffected dogs across 69 breeds were genotyped for the
insertion. Nonsyndromic cleft palate cases (n= 35) across 20 breeds
were genotyped. All genotypes were analyzed using STRand
software [56].
Real Time Quantitative PCR
Primer sequences were generated using Primer3Plus (http://
primer3plus.com/). A shared forward primer (59aaactcag-
tacctggcccttc 39) was designed with reverse primers unique to
wildtype (59ccatatcttcacctgtgtttgtg 39) and mutant (59aaactcag-
tacctggcccttc 39). Semi quantitative PCR using AmpliTaq Gold
DNA Polymerase was performed to test the quality of cDNA and
primers, to confirm product size and to check for the presence of
genomic DNA contamination. Real-time PCR was performed
using the Rotor-Gene SYBR Green PCR Kit (QIAGEN,
Valencia, CA) using a 2-step cycle protocol (45 cycles; Initial
denaturation-5 minutes at 95uC; Annealing- 15 seconds at 95uC;
Extension- 90 seconds at 95uC; Final Melt curve) on the Rotor
Gene Q real-time PCR system. Cerebral cortex from 3 neonatal
unaffected NSDTRs and 3 neonatal CP1 NSDTRs were run in
triplicates with each replicate containing 0.2 ng template cDNA.
cDNA was prepared as described above. All data was normalized
to the housekeeping gene B2M5 [58]. Amplification and takeoff
values were analyzed and graphed by REST2009 to determine
any significant expression differences in DLX5 and DLX6
transcript levels between control and affected cDNA samples [24].
Human Samples
The case cohort consisted of 92 samples from individuals with
nonsyndromic cleft lip with cleft palate (NSCLP) from the US, 59
samples from individuals with nonsyndromic cleft palate (NSCP)
from the US and the Philippines, and 46 samples from individuals
with cleft palate syndromes. The 46 syndromic samples consisted
of 30 samples from individuals with PRS and 16 samples from
individuals with additional congenital anomalies including club
foot, hearing loss, heart disease, and intellectual disability. 60
unrelated CEPH samples (CEU) were used as controls.
Sequencing of Human Samples
Primers were designed with Primer3 to cover the complete gene
region of DLX6 and all exons of DLX5 [55]. Primer sequences
and annealing temperatures are available in Table S5. The first
exon of DLX6 was sequenced using internal primers. PCR
products were sequenced on an ABI 3730XL (Functional
Biosciences, Inc., Madison, WI). Chromatograms were transferred
to a Unix workstation, base-called with PHRED (v.0.961028),
assembled with PHRAP (v. 0.960731), scanned by POLYPHRED
(v. 0.970312), and viewed with the CONSED program (v. 4.0).
The functional effects of variants were predicted using the Variant
Effect Predictor [59]. Genotypes from European or Asian
populations available from the 1000 Genomes Project and the
NHLBI Exome Sequencing Project were used as controls [25,26].
Fisher’s exact test, implemented in STATA (v12.1), was used to
test for differences in allele frequencies between NSCLP and
NSCP cases and controls [60]. For insertions or deletions where
allele frequencies were unavailable, we sequenced a set of 60
unrelated CEPH samples.
Genotyping of Human Samples
Three SNPs (rs2272280, rs3801290, and rs3213654) were
genotyped in 362 case-parent trios (1090 individuals) with
nonsyndromic cleft lip with or without cleft palate (NSCL/P)
from the US using TaqMan SNP Genotyping Assays (Life
Technologies, Grand Island, NY) on the ABI Prism 7900HT,
and were analyzed with SDS 2.3 software (Applied Biosystems,
Foster City, CA). The Family Based Association Test (FBAT) in
STATA (v12.1) was used to test for association these NSCL/P
case-parent trios [60].
Supporting Information
Table S1 Location of microsatellite markers on CFA14,
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gene annotation track.
(DOCX)
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